In vitro–in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|36|5|265-274

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.36, Iss.5, 2015-07, pp. : 265-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of FK506 (tacrolimus) in animal models of inflammation

By Singh Amanpreet   Naidu Pattipati S.   Patil C. S.   Kulkarni Shrinivas K.  

Inflammopharmacology, Vol. 11, Iss. 3, 2003-09 ,pp. : 249-257

VSP

Access to resources Recommend Favorite

Protective effect of FK506 (Tacrolimus) in pentylenetetrazol-induced kindling in mice

By Singh A.   Kumar G.   Naidu P.S.   Kulkarni S.K.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 853-860

Elsevier

Access to resources Recommend Favorite

Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats

By Fujii Y.   Takeuchi H.   Tanaka K.   Sakuma S.   Ohkubo Y.   Mutoh S.  

European Journal of Pharmacology, Vol. 456, Iss. 1, 2002-12 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation

By  

Current Drug Metabolism, Vol. 17, Iss. 5, 2016-06 ,pp. : 456-468

Bentham Science Publishers

Access to resources Recommend Favorite

FK506 does not affect cardiac contractility and adrenergic response in vitro

By Milting H.   Janssen P.M.L.   Wangemann T.   Kogler H.   Domeier E.   Seidler T.   Hakim K.   Grapow M.   Zeitz O.   Prestle J.   Zerkowski H.-R.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite